<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Biological Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CBAB4F77-AC8B-4E59-826D-D315999C1E39"><gtr:id>CBAB4F77-AC8B-4E59-826D-D315999C1E39</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:surname>Cooke</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6110"><gtr:id>678C580C-346F-4166-AAC4-5F78F9FF6324</gtr:id><gtr:title>Development of a DNA microarray as an approach to the surveillance of multiply antibiotic resistant hospital pathogens.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6110</gtr:grantReference><gtr:abstractText>Hospital-acquired infections due to antibiotic resistant bacteria are an increasing problem, for example methicillin resistant Staphylococcus aureus (MRSA). These infections, particularly of the bloodstream, are responsible for increased length of hospital stay, increased socio-economic costs and significant illness and mortality. Current methods for monitoring and control of these infections are based on classical microbiological techniques, which may be slow, and yield only limited information. Additional information on the potential of these bacteria to cause disease, and the antibiotic resistance genes they may carry, could be obtained by interrogating the genome using molecular probes. Gene-based approaches could provide information about the species/subtype of bacteria, nature of resistance genes, and potential for resistance to spread. This analysis would provide a better understanding of the relationships between isolates as well as their potential to cause disease. The principal aim of this project is to design and develop DNA microarrays or ?gene chips? (whereby genetic codes are spotted onto a glass slide), and assess whether they could be used to improve surveillance in high-risk hospital environments. The findings of this study could significantly enhance strategies for the effective prevention and control of spread of antibiotic resistance in hospitals.</gtr:abstractText><gtr:technicalSummary>Nosocomial infections due to multiply-antibiotic resistant microorganisms are an increasing problem. Notable examples include methicillin resistant Staphylococcus aureus, glycopeptide resistant enterococci, Pseudomonas aeruginosa and various enteric bacteria. Current surveillance methods are based mainly on microbiological techniques, which focus on either phenotypic traits (sensitivity testing, phage typing) or monitor physical rearrangements in the genome (pulse field gel patterns). We propose that detailed interrogation of the genome, using bioinformatics together with microarrays, could provide further valuable information on antibiotic resistant genes and potential pathogenicity of the isolates. This information would include the species/subtype of bacteria, potential pathogenicity, nature of resistance genes encoded and potential for spread, and the presence of virulence associated genes. Thus the principal aim of this project is to design and develop DNA microarrays, and assess whether these can be used to provide improved surveillance in high-risk hospital environments. To achieve this, microarrays will be constructed that will facilitate microbial identification, the genotyping of antibiotic resistance, the detection of virulence factors and the identification of mobile elements. After initial validation, targeted surveillance will be performed in adult critical care units of a large NHS Trust. The information obtained could potentially improve infection control practice and should significantly enhance strategies for the effective prevention of antibiotic resistance in hospitals. In addition, a full survey of antibiotic resistance genes, virulence factors, and the mobile elements that carry them, would allow the separate elements involved in the spread of multi-resistant hospital pathogens to be analysed for the first time.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>215511</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1C395AED-A467-413E-9BE0-5CFC3957649B</gtr:id><gtr:title>Characterization of the genomes of a diverse collection of Salmonella enterica serovar Typhimurium definitive phage type 104.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e144eb796ca375191fbb3db5afc0d967"><gtr:id>e144eb796ca375191fbb3db5afc0d967</gtr:id><gtr:otherNames>Cooke FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>crxd1LuUDjK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4E4CF08-5460-4EFC-A964-86CB1FBE4171</gtr:id><gtr:title>Ten years experience of Salmonella infections in Cambridge, UK.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da462e77525c8a7d9bd60c4b6923fe9f"><gtr:id>da462e77525c8a7d9bd60c4b6923fe9f</gtr:id><gtr:otherNames>Matheson N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>G2oU1Zo4kzN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EE525AE-12A6-4FA0-89D2-6F2199842A77</gtr:id><gtr:title>Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee95b2afa352803fddeac6b10c6d4427"><gtr:id>ee95b2afa352803fddeac6b10c6d4427</gtr:id><gtr:otherNames>Phan MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>Em5HmyyT2uQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB9FD9BB-4713-4956-9BB5-BDFBCCE56817</gtr:id><gtr:title>Prophage sequences defining hot spots of genome variation in Salmonella enterica serovar Typhimurium can be used to discriminate between field isolates.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e144eb796ca375191fbb3db5afc0d967"><gtr:id>e144eb796ca375191fbb3db5afc0d967</gtr:id><gtr:otherNames>Cooke FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>ppPFNd3gkQn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A296B494-4B9A-4AE3-82C0-D6014140ACF9</gtr:id><gtr:title>Cases of typhoid fever imported into England, Scotland and Wales (2000-2003).</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e144eb796ca375191fbb3db5afc0d967"><gtr:id>e144eb796ca375191fbb3db5afc0d967</gtr:id><gtr:otherNames>Cooke FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>qtADtwZfc36</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6110</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>